Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Bristol Myers News
CELG.R
BRISTOL MYERS SQUIBB CO
CELG.R
BRISTOL MYERS SQUIBB CO
Articles
Latest stories
FDA Approves Tislelizumab, Breyanzi, and CAR-T Therapies for Various Cancers
Authors
15
4 months
Bio
Science
FDA Advisory Committee Backs Geron's Imetelstat for MDS, BeiGene's TEVIMBRA for Esophageal Cancer, and Bristol Myers' Breyanzi for CLL and SLL
Authors
21
4 months
Bio
Crime
Science
FDA Raises Concerns Over Early Deaths in CAR-T Myeloma Trials, Debates Impact on Abecma and Carvykti Plans; Approves Mirum's Drug, Adds Boxed Warnings
Authors
26
4 months
Bio
Crime
Science
FDA Approves New Cancer Treatments; Geron's Drug Gets Advisers' Backing, Faces Approval Challenges
Authors
8
4 months
Bio
Crime
Science
Alnylam, Roche's Blood Pressure Drug Shows Positive Results; Alumis Secures $259M for Immune Dysfunction Therapies, TYK2, Psoriasis, Bristol Myers
Authors
7
4 months
Bio
Crime
Science
House Democrats Oppose Republican Attempts to Undermine Drug Price Reduction Efforts Amid Sen. Sanders Report and Pharmaceutical CEOs Hearing
Authors
5
5 months
Politics
Bristol Myers' Second Major Buy: Acquires RayzeBio for $4.1B Amid Stock Surge
Authors
9
6 months
Economics
Business
Bristol Myers to Pay $800 Million to Chinese Drugmaker, Sanofi Terminates Deal After US FTC Objections, AstraZeneca Acquires Icosavax for $1.1 Billion
Authors
14
7 months
China
Economics
World
Bayer Stock Hits Lowest Since 2009 After Blood-Thinner Trial Failure, Bristol Myers' Stock Slumps, Moody's Downgrades Outlook
Authors
7
7 months
Economics
Business
Previous
Next